Sonoma Pharmaceuticals, Inc. Profile Avatar - Palmy Investing

Sonoma Pharmaceuticals, Inc.

Sonoma Pharmaceuticals, Inc., develops and produces stabilized hypochlorous acid (HOCl) products for wound care, animal health care, eye care, oral care, and dermatological conditions in the United States, Latin America, Europe, and internationally. The …

Drug Manufacturers - Specialty & Generic
US, Woodstock [HQ]
US · Macroeconomic Factors/Risks · Forecasts

Macro

Sonoma Pharmaceuticals, Inc. mainly operates in US (Alpha-2: US, Alpha-3: USA)

United States
Analysis Results
B Overall Rating
19 Analyzed Indicators
B Annual Indicators Rating
16 Analyzed Indicators
B+ Monthly Indicators Rating
3 Analyzed Indicators
Breakdown

All indicators comes from high quality sources, such as the world bank, OECD, FRED and manuel datasets such as Premiums by Prof. Damodaran.

End of SNOA's Analysis
CIK: 1367083 CUSIP: 83558L204 ISIN: US83558L2043 LEI: - UEI: -
Secondary Listings
SNOA has no secondary listings inside our databases.